| MYRIAD GENETICS DL-,01 | 18,970 / +1,47% |
| 日期/時間 | 07.07. / 17:43 |
| 漲跌。 / 漲跌。(%) | 0,275 / +1,47% |
| Bid | 19,080 / 261 |
| Ask | 19,170 / 261 |
| 打開 | 18,695 |
| 過往收市 | 18,695 |
| 高 | 18,970 |
| 低 | 18,695 |
| 成交量 [EUR] | - |
| 成交量 [Units] | |
| Price fixings | 7 |
| ISIN | US62855J1043 |
| 符號 | MYD |
| 交易所 | gettex |
| 類型 | 股票 |
所有交易
| 交易所 | 最後的 | 成交量 | |
|---|---|---|---|
| NASDAQ | 19,2850 |  |
64.759 |
| Cboe US | 19,28 | |
4.837 |
| IEX | 19,38 | |
2.778 |
| TradeGate | 19,000 | |
350 |
| Hannover | 18,590 | |
0 |
| Frankfurt | 18,5800 | |
0 |
| Berlin | 18,595 | |
0 |
| München | 18,570 | |
0 |
| Hamburg | 18,590 | |
0 |
| Düsseldorf | 18,945 | |
0 |
| Lang & Schwa.. | 18,945 | |
|
| Stuttgart | 18,580 |  |
|
| gettex | 18,970 | |
|
| Quotrix | 18,6600 | |
|
| Xetra | 17,840 | 0 | |
| London Domes.. | 19,45 | 31 |
新聞
- Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care
14.03.2022 / 12:05 - GlobeNewswire - Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
12.03.2022 / 01:05 - GlobeNewswire - Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
08.03.2022 / 13:22 - GlobeNewswire - Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference
02.03.2022 / 22:30 - GlobeNewswire - Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
24.02.2022 / 15:00 - GlobeNewswire
Personal area
Click on 
to activate push quotes.
to activate push quotes.